AlloVir (ALVR)
(Delayed Data from NSDQ)
$0.79 USD
+0.04 (5.43%)
Updated Apr 23, 2024 03:59 PM ET
After-Market: $0.80 +0.01 (1.15%) 7:48 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Cash flow Statements
Fiscal Year End for AlloVir, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -190.42 | -168.71 | -171.96 | -69.78 | -23.84 |
Depreciation/Amortization & Depletion | 0.40 | 0.72 | 0.19 | 0.07 | 0.02 |
Net Change from Assets/Liabilities | 2.03 | -16.15 | 19.35 | -1.03 | 1.40 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 63.54 | 42.08 | 46.10 | 9.93 | 2.27 |
Net Cash From Operating Activities | -124.45 | -142.05 | -106.32 | -60.81 | -20.16 |
Property & Equipment | 0.00 | 0.00 | -0.03 | -0.24 | -0.34 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 37.99 | -80.48 | 186.01 | -169.26 | -64.31 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 37.99 | -80.48 | 185.98 | -169.50 | -64.64 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 70.50 | 126.96 | 0.23 | 295.45 | 121.25 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | -3.47 | -0.33 |
Net Cash from Financing Activities | 70.50 | 126.96 | 0.23 | 291.98 | 120.92 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | -0.04 | -0.09 | 0.00 |
Net Change In Cash & Equivalents | -15.97 | -95.57 | 79.85 | 61.58 | 36.12 |
Cash at Beginning of Period | 106.94 | 202.51 | 122.66 | 61.08 | 24.96 |
Cash at End of Period | 90.97 | 106.94 | 202.51 | 122.66 | 61.08 |
Diluted Net EPS | -1.83 | -2.20 | -2.74 | -2.59 | NA |
Fiscal Year End for AlloVir, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -190.42 | -130.72 | -86.45 | -41.18 |
Depreciation/Amortization & Depletion | NA | 0.40 | 0.26 | 0.17 | 0.09 |
Net Change from Assets/Liabilities | NA | 2.03 | 4.66 | 7.74 | -0.78 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 63.54 | 32.09 | 19.30 | 9.76 |
Net Cash From Operating Activities | NA | -124.45 | -93.72 | -59.24 | -32.12 |
Property & Equipment | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 37.99 | 12.77 | 79.62 | 41.72 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 37.99 | 12.77 | 79.62 | 41.72 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 70.50 | 70.48 | 70.48 | 0.00 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 70.50 | 70.48 | 70.48 | 0.00 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -15.97 | -10.47 | 90.86 | 9.61 |
Cash at Beginning of Period | NA | 106.94 | 106.94 | 106.94 | 106.94 |
Cash at End of Period | NA | 90.97 | 96.48 | 197.81 | 116.55 |
Diluted Net EPS | NA | -0.52 | -0.39 | -0.48 | -0.44 |